Bharat Immunologicals Current Valuation vs. Debt to Equity

Bharat Immunologicals Biologicals Corp Ltd -- India Stock  

INR 21.3  0.1  0.47%

The Drivers Module shows relationships between Bharat Immunologicals's most relevant fundamental drivers and provides multiple suggestions of what could possibly affect the performance of Bharat Immunologicals Biologicals Corp Ltd over time as well as its relative position and ranking within its peers. Check also Trending Equities

Bharat Immunologicals Debt to Equity vs. Current Valuation Fundamental Analysis

Bharat Immunologicals Biologicals Corp Ltd is rated below average in current valuation category among related companies. It is rated third in debt to equity category among related companies . The ratio of Current Valuation to Debt to Equity for Bharat Immunologicals Biologicals Corp Ltd is about  1,725,000,000 
Enterprise Value is a firm valuation proxy that approximates current market value of a company. It is typically used to determine takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that company has on its balance sheet. When takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Bharat Immunologicals 
Enterprise Value 
 = 
Market Cap + Debt 
-  
Cash 
=
862.5 M
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Bharat Immunologicals 
D/E 
 = 
Total Debt 
Total Equity 
=
0.5 %
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging barrowing against the capital invested by the owners.

Comparison

Debt to Equity Comparison
Bharat Immunologicals is currently under evaluation in debt to equity category among related companies.
Bharat Immunologicals Biologicals Corporation Limited, a biotechnology company, manufactures and markets a range of pharmaceuticals solutions in India. more
NameBharat Immunologicals Biologicals Corp Ltd
Macroaxis Advice
InstrumentIndia Stock Stocks Directory
ExchangeBombay Stock Exchange
CurrencyINR
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Find Alpha
Equity Screener
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals, sectors and families
Research Equities
Insiders Screener
Find insiders across different sectors to evaluate their impact on performance and growth of their entities
Research Insiders